Last updated 2026-08-21
- Raised $675k IPO, Oct 2020
Total raised
$675K
Stage
—
Founded
1990
Headcount
—
HQ
Tel Aviv, Israel
Sector
Biotechnology
About
NextGen Biomed Ltd. is an Israeli pharmaceutical company focused on the development and marketing of medical equipment and treatments. Their product portfolio includes solutions for psoriasis and diabetes management, as well as various medical instruments. The company is publicly traded on the Tel Aviv Stock Exchange and is currently in the process of merging with Scentech Medical.
Funding history · 1 round · $675K total
2020-10
IPO
$675K
Q&A
- What is NextGen Biomed Ltd.'s primary focus?
- NextGen Biomed Ltd. is an Israeli pharmaceutical company that develops and markets medical equipment and treatments, including solutions for psoriasis and diabetes management.
- When was NextGen Biomed Ltd. founded?
- NextGen Biomed Ltd. was founded in 1990.
- Is NextGen Biomed Ltd. a publicly traded company?
- Yes, NextGen Biomed Ltd. is publicly traded on the Tel Aviv Stock Exchange.
- What is the status of NextGen Biomed Ltd.'s merger with Scentech Medical?
- NextGen Biomed Ltd. is currently in the process of merging with Scentech Medical.
- When did NextGen Biomed Ltd. complete its IPO?
- NextGen Biomed Ltd. completed its IPO in October 2020, raising $675,000.
- Who is the current CEO and General Manager of NextGen Biomed Ltd.?
- Harel Hershtik was appointed CEO & GM of NextGen Biomed Ltd. in November 2022.
- Does NextGen Biomed Ltd. have any subsidiaries?
- Yes, DermiPsor is a subsidiary of NextGen Biomed Ltd., located in Tel Aviv, Israel.
Team · 1
Harel Hershtik
CEO & GM
Sectors & technology
Primary sector
Biotechnology
Technologies
Target customers
Business model
B2BB2C
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | nextgen-biomed.com |
|---|
Identifiers & details
| Legal name | NextGen Biomed Ltd. |
|---|---|
| Founded | 1990 |